|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| G01N 33/50 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3699198 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20167215.1 |
| Date of filing the European patent application | 2015-11-17 | |
| (97) | Date of publication of the European application | 2020-08-26 |
| (45) | Date of publication and mention of the grant of the patent | 2025-03-26 |
| (46) | Date of publication of the claims translation | 2025-05-12 |
| (30) | Number | Date | Country code |
| 201462080716 P | 2014-11-17 | US | |
| 201562160788 P | 2015-05-13 | US |
| (72) |
SMITH, Eric , US
DAVIS, Samuel , US
VARGHESE, Bindu , US
KIRSHNER, Jessica R. , US
THURSTON, Gavin , US
LOWY, Israel , US
BROWNSTEIN, Carrie , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Būdai navikams gydyti naudojant CD3×CD20 bispecifinį antikūną |
| METHODS FOR TUMOR TREATMENT USING CD3XCD20 BISPECIFIC ANTIBODY |